Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation
about
Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activationCaveolin-1 triggers T-cell activation via CD26 in association with CARMA1Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activationPhosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathwaysBcl10 can promote survival of antigen-stimulated B lymphocytesAlternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-κB activation and endoplasmic reticulum stress-induced cell deathCARMA1 is required for Akt-mediated NF-kappaB activation in T cells.Nore1B regulates TCR signaling via Ras and Carma1PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1Signaling advances from immunogenetics to immunogenomicsDistinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organsThe paracaspase MALT1: biological function and potential for therapeutic inhibitionRole of T cell-nuclear factor κB in transplantationIndoctrinating T cells to attack pathogens through homeschoolingStructural Insights into the Assembly of CARMA1 and BCL10Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulatorNF-kappaB and the immune responseA Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusionsDeciphering the pathway from the TCR to NF-kappaBRip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activationComplex and dynamic redistribution of NF-kappaB signaling intermediates in response to T cell receptor stimulationMAGUK-controlled ubiquitination of CARMA1 modulates lymphocyte NF-kappaB activity.The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.A loss-of-function RNA interference screen for molecular targets in cancer.Spatial differences in active caspase-8 defines its role in T-cell activation versus cell deathCommitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery.Transcriptional target-based expression cloning of immunoregulatory moleculesChemical biology strategy reveals pathway-selective inhibitor of NF-kappaB activation induced by protein kinase CCARMA1-mediated NF-kappaB and JNK activation in lymphocytes.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.Cell-intrinsic NF-κB activation is critical for the development of natural regulatory T cells in mice.The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.Molecular basis of lysophosphatidic acid-induced NF-κB activationMALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cellsDesign, Assessment, and in vivo Evaluation of a Computational Model Illustrating the Role of CAV1 in CD4(+) T-lymphocytes.Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
P2860
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
P248
Q24295025-40A0F034-C9C0-42CA-8D19-6A58A8E407B9Q24296240-99196967-1486-4C20-96CD-E90A3D83C407Q24298225-FD94CA4F-4D25-4821-84F7-49E99042C0ABQ24300430-F29BFC73-1639-491C-BD68-633D423D48A9Q24301605-960FF246-F603-4A66-AF3E-E50154AD983EQ24339441-70F0F7AC-4AD3-4F44-9C05-DFD8CB360F9BQ24548028-D6001EE9-A97C-4F18-8EBE-1191A6803FD4Q24633118-2F72BF72-9AF1-485C-B646-2D665318FD4FQ24646391-32E2728C-41E1-4A86-A4F2-D9AD135D191FQ24793529-FB61293D-B886-4485-B9BC-05EFFB0F1714Q24801085-E67E5B18-D2CE-4A52-A457-4A3EF0D5FD01Q26778357-8B673C39-430C-44B3-B730-F4EB76CC9882Q26852416-125A0DD9-110E-450D-BD86-00BF70315B51Q27012849-FB5DEC2B-8E29-4D98-A50C-CE274A98CFB0Q27671461-5AE6315B-BD23-4DB6-8B71-FFCB92C243A8Q28117437-75479C55-DEDB-427A-A21B-B960AD13B176Q28265675-5F1D4279-F7D5-4A61-8A2D-B4920F3F8374Q28271031-5E016CDF-E9B7-4333-BB65-D03D2437D3C0Q28287278-0DB54633-9952-4A36-8C5B-F05F001315FFQ28294015-003105F2-1BDC-4D80-B12A-E89EEEC5B2CDQ28510312-AAFE701F-CA2B-4AEB-9543-E1A6018D4B22Q28589013-48F19689-1D60-4F53-903E-6BF9E4252059Q30157021-35DF37E4-C0FE-4148-A432-2AA2AFE42931Q30157639-28E72FFE-588E-49B8-ABAB-1DFCBBA83B6BQ33237976-9AEE6622-C831-4ADB-A250-1A4A23AC69C2Q33350789-18CB2C1F-7405-4926-A344-8ED7C041F185Q33414811-B8978806-1E51-4CDD-ACE1-CC7B45475B37Q33523540-EFB0689C-B274-42F2-8BF1-FF537461CBF6Q33530203-6B80F840-3895-444A-9203-6FEA55131C17Q33885629-B16DA51D-B974-4997-B641-AFF12D36390BQ33889168-74855864-405C-40BF-B60A-BB7485C2E647Q33916718-1B0D255F-DDDF-4F7F-975B-42FBF5B59BBCQ34070358-7C6B82FC-3572-41D8-98F4-11921861026DQ34080225-5D01C01A-C8F8-4B3B-8910-0C09E24C0BD9Q34126537-D7E20015-7D4C-4BB2-AB09-242B192E175EQ34432953-1B48EA05-3E56-451E-9AD4-7FAA097FC0A9Q34500164-C7B0BBCF-5336-4C87-9A93-19F4FC4ADB9CQ34582700-D2985146-01FC-46A4-A185-3EB7C9B14538Q34637731-C80E07EE-3841-4BF6-BFEA-4ADED40660EDQ34683996-623DC02B-743F-40BF-8F47-F4BE33445881
P2860
Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation
description
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Juli 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/07/15)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/07/15)
@nl
наукова стаття, опублікована в липні 2003
@uk
مقالة علمية (نشرت في 15-7-2003)
@ar
name
Requirement for CARMA1 in anti ...... n and lymphocyte proliferation
@ast
Requirement for CARMA1 in anti ...... n and lymphocyte proliferation
@en
Requirement for CARMA1 in anti ...... n and lymphocyte proliferation
@nl
type
label
Requirement for CARMA1 in anti ...... n and lymphocyte proliferation
@ast
Requirement for CARMA1 in anti ...... n and lymphocyte proliferation
@en
Requirement for CARMA1 in anti ...... n and lymphocyte proliferation
@nl
prefLabel
Requirement for CARMA1 in anti ...... n and lymphocyte proliferation
@ast
Requirement for CARMA1 in anti ...... n and lymphocyte proliferation
@en
Requirement for CARMA1 in anti ...... n and lymphocyte proliferation
@nl
P2093
P921
P3181
P1433
P1476
Requirement for CARMA1 in anti ...... n and lymphocyte proliferation
@en
P2093
Benoît Favier
Björn Albrecht
Dan R. Littman
Kanchan Mirchandani
Margot Thome
Mary-Jean Sunshine
Takeshi Egawa
William O'Brien
P304
P3181
P356
10.1016/S0960-9822(03)00491-3
P407
P577
2003-07-15T00:00:00Z